Short-Term Comparison of Switching to Brolucizumab or Faricimab from Aflibercept in Neovascular AMD Patients
<i>Background and Objectives</i>: In this study, our objective was to assess and compare the changes in visual and structural outcomes among patients with neovascular age-related macular degeneration (nAMD) who were switched from intravitreal aflibercept (IVA) to either intravitreal brolucizumab (IV...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2024-07-01
|
| coleção: | Medicina |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/1648-9144/60/7/1170 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
